| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Acetaminophen | FAERS: 51 | US FAERS | |
| 2 | Loratadine | FAERS: 50 | US FAERS | |
| 3 | Naproxen | FAERS: 23 | US FAERS | |
| 4 | Ibuprofen | FAERS: 20 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Cetirizine | FAERS: 6 | US FAERS | |
| 6 | Diphenhydramine | FAERS: 3 | US FAERS | |
| 7 | Loratadine and pseudoephedrine sulfate | FAERS: 3 | US FAERS | |
| 8 | Canagliflozin | FAERS: 2 | US FAERS | |
| 9 | Dextromethorphan | FAERS: 2 | US FAERS | |
| 10 | Diphenhydramine | FAERS: 2 | US FAERS | |
| 11 | Famotidine | FAERS: 2 | US FAERS | |
| 12 | Nebivolol | FAERS: 2 | US FAERS | |
| 13 | Paliperidone Palmitate | FAERS: 2 | OFFSIDES US FAERS | |
| 14 | acetaminophen, aspirin, caffeine drug combination | FAERS: 2 | US FAERS | |
| 15 | fexofenadine | FAERS: 2 | US FAERS | |
| 16 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 1 | US FAERS | |
| 17 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 18 | Aleve PM | FAERS: 1 | US FAERS | |
| 19 | Aripiprazole | FAERS: 1 | US FAERS | |
| 20 | Buprenorphine | FAERS: 1 | US FAERS | |
| 21 | Epinephrine | FAERS: 1 | US FAERS | |
| 22 | Ethylene Glycol | FAERS: 1 | US FAERS | |
| 23 | Mebendazole | FAERS: 1 | US FAERS | |
| 24 | Methylphenidate | FAERS: 1 | US FAERS | |
| 25 | Ondansetron | FAERS: 1 | US FAERS | |
| 26 | Oxandrolone | FAERS: 1 | US FAERS | |
| 27 | Pseudoephedrine | FAERS: 1 | US FAERS | |
| 28 | Thyroxine | FAERS: 1 | US FAERS | |
| 29 | Tramadol | FAERS: 1 | US FAERS | |
| 30 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 31 | Vilazodone Hydrochloride | FAERS: 1 | US FAERS | |
| 32 | tetrahydrozoline | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.